SEC reporting owner

PAPADOPOULOS STELIOS SEC insider disclosures

Explore PAPADOPOULOS STELIOS's reporting-owner identity, issuer relationships, purchases, sales and SEC filing receipts.

As of 2026-10-07T00:29:11.873Z

Reporting owner CIK
0001202098
Issuers
9
Coverage
verified

Issuer relationships

A reporting-owner CIK identifies the filer across issuer relationships and name aliases. A filer may be an individual or an organization; the filing role is the relevant evidence.

SGX PHARMACEUTICALS, INC.0001125603SGXPNoYes
EXELIXIS, INC.0000939767EXELNoYes
ANADYS PHARMACEUTICALS INC0001128495ANDSNoYes
GENVEC INC0000934473GNVCNoYes
BIOGEN INC.0000875045BIIBNoYes
BG Medicine, Inc.0001407038BGMDNoYes
Regulus Therapeutics Inc.0001505512RGLSNoYes
Eucrates Biomedical Acquisition Corp.0001822929EUCRNoYes
Ovid Therapeutics Inc.0001636651OVIDNoYes

Recent SEC transactions

Code P identifies a purchase, S a sale and A an award. Awards and open-market purchases describe different events. Use the public availability date when deciding when a researcher could have known about the transaction.

2026-05-302026-05-27EXELA8,367Not reported
2026-04-102026-04-07OVIDA17,578Not reported
2026-03-032026-02-26OVIDA65,000Not reported
2025-11-142025-11-12EXELS100,000Not reported
2025-05-312025-05-29EXELA9,812Not reported
2025-05-172025-05-15EXELS15,874Not reported
2025-05-172025-05-15EXELS20,634Not reported
2025-05-012025-04-30RGLSA62,500Not reported
2025-03-052025-03-03OVIDA90,000Not reported

Up to 50 transactions from the recent two-year owner window.

Source evidence and strategy eligibility

The transactions below come from filings; a historical tracker separately simulates following eligible events. Joint filers can report the same transaction, and an owner can have filings at multiple companies. Public availability, amendment lineage and verified coverage determine which events a historical tracker may use.

The current directory marks this owner's filing coverage verified.